Summarizing, we investigated the contexture of ESCCs IM and demonstrate increased intraepithelial CD3+ TILs and high PD-L1 expression on tumor cells to be independent predictors of a beneficial clinical outcome in ESCC. The gene discussed is CD274; the disease is neoplasm.